Sitemap
-
Contact
-
At BioInvent, our goal is to use our expertise in antibody drug development to provide innovative antibody therapies for patients with unmet serious or life-threatening diseases.
Home
About BioInvent
Products
Partners
Science
Investors
Media Centre
Strategy
Management Team
Board of Directors
Corporate Citizenship
Careers
Pipeline
Oncology
Atherosclerosis
Thrombosis
Clinical Trials
Product Alliances
Technology Partnerships
Monoclonal Antibodies
n-CoDeR®
Biopanning
Manufacturing
Biologic and Preclinical Expertise
The Share
Financial Reports
Press Releases
Presentations
Investor Information
Corporate Governance
Investor Contact
Subscription Service
Press Releases
Downloads
Events
Press Releases
Downloads
»
Antibody Therapeutics
Scientific publications
Abstracts / posters
Investor presentations
Events
Press Releases
2009
2008
2007
2006
2005
2004
2003
2002
2001
BioInvent International
SE-223 70 Lund, Sweden Visiting: Sölvegatan 41, Lund, Sweden Tel: +46 (0)46-286 85 50 E-mail:
info@bioinvent.com